Sermorelin (GRF 1-29)

Sermorelin (GHRH 1-29) and CJC-1295 (Mod GRF 1-29 No DAC) are both GHRH analogs that stimulate endogenous GH production. Differences: Sermorelin — FDA-approved (1997, Geref), 30+ years clinical base, 10–20 min half-life — milder, more natural. CJC-1295 No DAC — modified analog, 30 min half-life, somewhat stronger effect on GH secretion, available in Pen Peptide pen format. Sermorelin — better start for beginners and people 35–45 years, also for those wanting FDA-validated history. CJC-1295 No DAC — for people 40+ with more pronounced anti-aging needs, or as next step after Sermorelin course. Often combined with Ipamorelin for synergy.

Week 2-3 — improved sleep and energy. 4-6 — more muscle tone and recovery. 8-12 — noticeable fat reduction (especially abdominal), skin improvement, increased motivation for sports. IGF-1 increases by 20-40% over 8-12 weeks.

FDA-approved since 1997 — most studied GHRH analog. Safe with cyclic use (3-4 courses/year) under IGF-1 monitoring. Long-term risks significantly lower than synthetic HGH because natural regulation is preserved. Mandatory monitoring: IGF-1, fasting glucose, lipid profile before course and after 8 weeks.

Yes, this is the classic "GH stack" in anti-aging medicine — Sermorelin + Ipamorelin injected together subcutaneously before bedtime. Synergistic effect: Sermorelin (GHRH) activates GH synthesis, Ipamorelin (ghrelin-mimetic, GHSR) stimulates its secretion through different receptor — resulting in doubled GH peak compared to each separately. Standard doses: Sermorelin 200–300 mcg + Ipamorelin 200–300 mcg together evening, 5 days per week. 12-week course. IGF-1 monitoring mandatory. Sermorelin not included in Pen Peptide lineup; Ipamorelin available in pen format — DOZA advises on combination selection.

Not indicated: active oncology or in remission <5 years, pregnancy and lactation, children and adolescents without official GH deficiency diagnosis, uncontrolled diabetes, severe renal/hepatic insufficiency, critical illness in ICU. Mandatory endocrinologist consultation before starting.

Currently — no. Sermorelin is not included in main Pen Peptide pre-mixed pen lineup (dtspharmacy.com Sermorelin collection is empty). However, Sermorelin continues to be supplied through specialized FDA-registered compounding pharmacies in the US and other channels. Check availability with DOZA consultant — cost, form and protocol are individually coordinated. For similar effect with guaranteed availability choose CJC-1295 No DAC from Pen Peptide.

Inject subcutaneously in abdomen or anterior thigh, rotating sites, 30–60 minutes before bedtime. Mandatory condition: empty stomach (minimum 2 hours after dinner) — otherwise food in blood will suppress natural GH peak. If Sermorelin is supplied as lyophilized powder — reconstitute with bacteriostatic water, then store refrigerated 2–8°C up to 14 days. Don't mix with other substances in same syringe (can inject Sermorelin and Ipamorelin as separate injections consecutively). Before first injection — detailed DOZA specialist consultation.

Exact course cost is individually coordinated by DOZA consultant, since Sermorelin is not standard Pen Peptide product and is supplied from limited sources. In global practice, 12-week course costs approximately 600–1200 USD (compounding pharmacy in US). At DOZA cost is optimized for Ukrainian market. Alternative with guaranteed availability and lower price — CJC-1295 No DAC from Pen Peptide (available at DOZA).